Genmab Adr (GMAB)

Jan 17, 2025

GMAB vs. QGEN: Which Stock Is the Better Value Option? - MSN

Jan 17, 2025

Jan 14, 2025

Genmab (GMAB) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Jan 14, 2025

Jan 14, 2025

Are Investors Undervaluing Genmab (GMAB) Right Now? - Yahoo Finance

Jan 14, 2025

Jan 03, 2025

Genmab to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire Inc.

Jan 03, 2025

Nov 18, 2024

10 Biggest Biotechnology Companies - Investopedia

Nov 18, 2024

Nov 12, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Nov 12, 2024

Oct 16, 2024

Is the Options Market Predicting a Spike in Genmab (GMAB) Stock? - Yahoo Finance

Oct 16, 2024

Oct 15, 2024

Is Genmab (GMAB) Stock Undervalued Right Now? - Yahoo Finance

Oct 15, 2024

Oct 08, 2024

GMAB or INCY: Which Is the Better Value Stock Right Now? - Yahoo Finance

Oct 08, 2024

Oct 08, 2024

Down -14.68% in 4 Weeks, Here's Why Genmab (GMAB) Looks Ripe for a Turnaround - Yahoo Finance

Oct 08, 2024

Sep 24, 2024

Market Resilience: Genmab ADR (GMAB) Finishes Weak at 24.14, Down -5.44 - The Dwinnex

Sep 24, 2024

Sep 19, 2024

GANDHIM.APPL Share Price Today Up 13% - Equitymaster

Sep 19, 2024

Sep 18, 2024

Glenmark Pharma Share Price Today Down 3% - Equitymaster

Sep 18, 2024

Sep 16, 2024

Post-Trade Analysis: Genmab ADR (GMAB) Climbs 1.55, Closing at 26.90 - The Dwinnex

Sep 16, 2024

Sep 04, 2024

Market Recap: Genmab ADR (GMAB)’s Negative Momentum, Closing at 27.41 - The Dwinnex

Sep 04, 2024

Aug 06, 2024

All You Need to Know About Genmab (GMAB) Rating Upgrade to Strong Buy - MSN

Aug 06, 2024

Aug 05, 2024

BioNTech's Loss Quadruples as COVID-19 Vaccine Demand Falls - Yahoo Finance

Aug 05, 2024

Aug 02, 2024

Wall Street Analysts Think Genmab (GMAB) Could Surge 45.08%: Read This Before Placing a Bet - Yahoo Finance

Aug 02, 2024

Jul 25, 2024

GMAB vs. CSLLY: Which Stock Is the Better Value Option? - Yahoo Finance

Jul 25, 2024

Jul 17, 2024

Wall Street Analysts Believe Genmab (GMAB) Could Rally 52.33%: Here's is How to Trade - Yahoo Finance Australia

Jul 17, 2024

Jul 15, 2024

RBC Capital upgrades Genmab stock amid strong pipeline prospects - Investing.com

Jul 15, 2024

Jul 09, 2024

GMAB or TECH: Which Is the Better Value Stock Right Now? - Yahoo Finance

Jul 09, 2024

Jul 08, 2024

GMAB vs. TECH: Which Stock Is the Better Value Option? - Yahoo Finance

Jul 08, 2024

Jun 27, 2024

FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma - Yahoo Finance

Jun 27, 2024

Apr 10, 2024

GMAB: 3 Biotech Stocks Gaining Altitude and Interest - StockNews.com

Apr 10, 2024

Apr 03, 2024

Genmab's 'Evolution' Continues With A $1.8 Billion Deal; But Shares Slip - Investor's Business Daily

Apr 03, 2024

Mar 01, 2024

GMAB: Bank on the Future Returns With These 3 Biotech Stocks - StockNews.com

Mar 01, 2024

Jan 17, 2024

New Strong Buy Stocks for January 17th - Yahoo Finance

Jan 17, 2024

Dec 12, 2023

GMAB: 3 Biotech Stocks to Boost Portfolios - StockNews.com

Dec 12, 2023

Nov 10, 2023

GMAB: 3 Biotech Stocks to Watch in November - StockNews.com

Nov 10, 2023

Sep 05, 2023

Zai Lab ADR surges after Seagen, Genmab release cervical cancer treatment results - MarketWatch

Sep 05, 2023

May 19, 2023

GMAB: 2 Explosive Biotech Stocks to Own - StockNews.com

May 19, 2023

Feb 27, 2023

Stocks Generating Improved Relative Strength: Genmab ADR - Investor's Business Daily

Feb 27, 2023

Feb 23, 2023

Stocks Flashing Renewed Technical Strength: Ascendis Pharma ADR - Investor's Business Daily

Feb 23, 2023

Feb 10, 2023

Moderna Stock Getting Closer To Key Technical Benchmark - Inkl

Feb 10, 2023

Feb 06, 2023

Stock Upgrades: Legend Biotech ADR Shows Rising Relative Strength - Investor's Business Daily

Feb 06, 2023

Jan 23, 2023

GILD or GMAB: Which Is the Better Value Stock Right Now? - Yahoo News Canada

Jan 23, 2023

Jan 18, 2023

Ascendis Pharma ADR Scores Relative Strength Rating Upgrade; Hits Key Benchmark - Investor's Business Daily

Jan 18, 2023

Dec 12, 2022

Is Elevance Health, Inc. (ELV) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Dec 12, 2022

Nov 29, 2022

Horizon Therapeutics Is A Stock With Rising Relative Strength - Investor's Business Daily

Nov 29, 2022

Nov 24, 2022

Genmab's chief development officer sells shares in US - MedWatch

Nov 24, 2022

Aug 31, 2022

Stocks To Watch: Genmab Sees Relative Strength Rating Jump To 82 - Investor's Business Daily

Aug 31, 2022

Aug 09, 2022

Zealand Pharma to delist in US - MedWatch

Aug 09, 2022

May 10, 2022

Should You Buy Genmab (GMAB) Ahead of Earnings? - Yahoo Finance

May 10, 2022

Mar 29, 2021

Inside Genmab's blockbuster IPO - IR Magazine

Mar 29, 2021

Feb 24, 2021

Pipeline of Proprietary Antibodies - flow – Deutsche Bank

Feb 24, 2021

Jan 13, 2021

Emergent BioSolutions Sees Its Composite Rating Rise To 97 - Investor's Business Daily

Jan 13, 2021

Jan 05, 2021

Genmab (GMAB) Begins Phase III Study on Cervical Cancer Drug - Yahoo Finance

Jan 05, 2021

Jun 16, 2020

The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO - Benzinga

Jun 16, 2020

Aug 19, 2019

Genmab's offering and listing in the USA - Bech-Bruun

Aug 19, 2019

Aug 08, 2019

Genmab AS (GMAB) Stock Price, Trades & News - GuruFocus.com

Aug 08, 2019

Jul 15, 2019

Genmab IPO: What You Need To Know - Benzinga

Jul 15, 2019